Jazz pharmaceuticals
Related questions
Trends
Related Searches
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's considerable products is the United States Food and Drug Administration...
- Safe
- United States
- Encrypted
- 23 yrs old
- 13 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
WebJazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life ...
- Safe
- United States
- Encrypted
- 21 yrs old
- 10 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
WebJAZZ: Rating decreased to a HOLDJAZZ PHARMACEUTICALS PLC has an Investment Rating of HOLD; a target price of $159.000000; an Industry Subrating of Medium; a …
- Safe
- United States
- Encrypted
- 29 yrs old
- 19 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Our Medicines. We operate or partner to make our medicines available in nearly 75 countries. To report an adverse event or a product complaint, or to request …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance August 2, 2023 Jazz Pharmaceuticals …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
WebCORRECTED: Jazz Pharmaceuticals now sees 2021 loss per share $4.70 to $2.00 vs. prior guidance for EPS of $8.30 to $1.045. Jun. 17, 2021 at 7:57 a.m. ET by Ciara Linnane.
- Safe
- United States
- Encrypted
- 26 yrs old
- 369 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Jazz Pharmaceuticals plc. Ireland: +353 1 637 2141 US: 215-867-4948. /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
August 2, 2023. Jazz Pharmaceuticals enters into Letter of Intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Rylaze®, helping address the unmet …
- Safe
- United States
- Encrypted
- 21 yrs old
- 279,827 Site Rank
- Report Card
- Site Info
- Domain Check
- Site Overview
Related Searches
{{domain}}
WEBSITE REPORT CARD
WEBSITE REPORT CARD
-
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information